Symptomatic Treatment for Viral Upper Respiratory Infection with One Week of Cough
For an adult with a viral upper respiratory infection and cough lasting one week, use a first-generation antihistamine/decongestant combination (such as brompheniramine with sustained-release pseudoephedrine) plus naproxen for symptomatic relief. 1
Treatment Algorithm
First-Line Therapy
- Combination antihistamine/decongestant: First-generation antihistamine (brompheniramine) with sustained-release pseudoephedrine is the most effective treatment for cough associated with the common cold 1, 2
- Add naproxen: This NSAID helps decrease cough in the setting of viral upper respiratory infections 1
What NOT to Use
- Avoid newer-generation nonsedating antihistamines - they are ineffective for reducing cough and should not be used 1
- Do not routinely prescribe:
Key Evidence and Rationale
The 2006 CHEST guidelines provide Grade A recommendation (fair evidence, substantial benefit) for first-generation antihistamine/decongestant combinations based on their effectiveness in treating acute cough, post-nasal drip, and throat clearing associated with the common cold 1. This represents the highest quality guideline recommendation available.
The 2020 CHEST expert panel found insufficient evidence to support routine prescription of most common therapies for acute bronchitis 3. A rigorous multicenter RCT of 416 adults showed no significant difference in days with frequent cough between ibuprofen (9 days), amoxicillin-clavulanic acid (11 days), and placebo (11 days) 3.
Important Clinical Considerations
Natural History
Approximately 25% of patients continue to have cough symptoms at day 14 even without treatment 1. This is normal and does not indicate bacterial infection or need for antibiotics.
When to Consider Bacterial Infection
Do not diagnose bacterial sinusitis during the first week of symptoms 1. Even though 87% of patients with recent-onset colds show sinus abnormalities on CT scan, 79% resolve without antibiotics by days 13-20 1. Clinical judgment is required after one week if symptoms persist or worsen.
Common Pitfalls to Avoid
- Prescribing antibiotics for colored sputum alone - this does not indicate bacterial infection in the first week 3
- Using newer antihistamines (cetirizine, loratadine, fexofenadine) - these lack the anticholinergic properties needed for symptom relief 1
- Expecting immediate resolution - cough can persist 2-3 weeks as part of normal viral illness course 2
If Productive Cough Develops
For patients who develop significant sputum production (elderly, young children, those with chest conditions), mucoactive agents like ambroxol may be considered to improve mucociliary clearance 4, 5, though this represents lower-quality evidence than the guideline recommendations for first-generation antihistamine/decongestant combinations.